Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Hideo Machimura"'
Autor:
Yoshimi Muta, Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone, Daisuke Suzuki, Daisuke Tsuriya, Hideo Machimura, Hidetoshi Shimura, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Keizo Kanasaki, Kouichi Tamura, Masaaki Miyauchi, Masuo Saburi, Miwa Morita, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Shunichiro Tsukamoto, Takashi Murata, Takaya Matsushita, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yuichi Takashi, Daiji Kawanami
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Accumulating evidence has demonstrated that both SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1Ra) have protective effects in patients with diabetic kidney disease. Combination therapy with SGLT2i and GLP1Ra is commonly used in patients
Externí odkaz:
https://doaj.org/article/e387d4d5ba7242e08853f9abf1debf8d
Autor:
Ikuro Matsuba, Takehiro Kawata, Kotaro Iemitsu, Taro Asakura, Hikaru Amemiya, Masashi Ishikawa, Syogo Ito, Mizuki Kaneshiro, Akira Kanamori, Akira Kubota, Kazuaki Shinoda, Masahiko Takai, Tetsuo Takuma, Masahiro Takihata, Hiroshi Takeda, Keiji Tanaka, Yoko Matsuzawa, Hideo Machimura, Fuyuki Minagawa, Nobuaki Minami, Atsuko Mokubo, Masaaki Miyakawa, Yasuo Terauchi, Yasushi Tanaka
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Abstract Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in w
Externí odkaz:
https://doaj.org/article/ef16d02909194cbd8964f418883bb465
Autor:
Kazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Kazuyoshi Sato, Masaaki Miyakawa
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 7, Pp 637-644 (2019)
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Externí odkaz:
https://doaj.org/article/b1b31d2ac3f746d1be93392f3402d38a
Autor:
Kazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Masaaki Miyakawa
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Aim. The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure pa
Externí odkaz:
https://doaj.org/article/1fa7d3057ac64d3b92a640d8898447ba
Autor:
Ikuro, Matsuba, Takehiro, Kawata, Miho, Ajima, Shinichi, Umezawa, Mizuki, Kaneshiro, Taro, Asakura, Hideo, Machimura, Tasuku, Sawa, Keiji, Tanaka, Hiroshi, Takeda, Takeshi, Imaoka, Akira, Kanamori
Publikováno v:
Diabetes Therapy. 13:265-274
MOSAIc was a multinational, non-interventional, prospective, observational cohort study designed to provide an understanding of the specific challenges associated with intensification of initial insulin therapy in patients with type 2 diabetes mellit
Autor:
Kouta Aoyama, Shun Ito, Masaaki Miyakawa, Kouichi Tamura, Nobumichi Saito, Tomoya Umezono, Shinichi Umezawa, Toshimasa Hishiki, Fuyuki Minagawa, Hareaki Yamamoto, Masao Toyoda, Daisuke Suzuki, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Togo Aoyama, Kazuyoshi Sato, Hiroshi Takeda, Hideo Machimura, Yutaka Hatori, Hisakazu Degawa, Takayuki Furuki, Kohsuke Minamisawa, Masahiro Hayashi, Yoshiro Hamada, Hiroyuki Sakai, Yoshiro Suzuki, Tomohiko Kanaoka, Akira Kanamori, Nobuo Hatori
Publikováno v:
Diabetes Technology & Therapeutics. 23:110-119
Aim: Sodium–glucose cotransporter 2 inhibitors (SGLT2is) provide renal protection in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to elucidate the renal effects of long-...
Autor:
Hareaki Yamamoto, Akira Kanamori, Daisuke Suzuki, Masao Toyoda, Nobuo Hatori, Hisakazu Degawa, Kazuyoshi Sato, Takayuki Furuki, Hiroyuki Sakai, Kouta Aoyama, Kouichi Tamura, Keiichi Chin, Masahiro Takihata, Shun Ito, Fuyuki Minagawa, Masahiro Hayashi, Toshimasa Hishiki, Kohsuke Minamisawa, Yoshiro Suzuki, Hiroshi Takeda, Togo Aoyama, Hideo Machimura, Yutaka Hatori, Shinichi Umezawa, Masaaki Miyakawa, Yoshiro Hamada, Tomoya Umezono, Kazuo Kobayashi
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Sodium–glucose cotransporter 2 inhibitors (SGLT2i) improve renal outcome in patients with type 2 diabetes mellitus, but the mechanism is not fully understood. The aim of this retrospective study was to assess the association of ac
Autor:
Akira Kanamori, Masahiro Takihata, Kotaro Iemitsu, Hikaru Amemiya, Mizuki Kaneshiro, Yoko Matsuzawa, Masashi Ishikawa, Keiji Tanaka, Hiroshi Takeda, Kazuaki Shinoda, Akira Kubota, Takehiro Kawata, Tetsuo Takuma, Nobuaki Minami, Yasushi Tanaka, Hideo Machimura, Ikuro Matsuba, Atsuko Mokubo, Masaaki Miyakawa, Masahiko Takai, Yasuo Terauchi, Syogo Ito, Taro Asakura, Fuyuki Minagawa
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in which ipra
Autor:
Atsuko Mokubo, Masahiko Takai, Mizuki Kaneshiro, Takehiro Kawata, Akira Kanamori, Yasushi Tanaka, Tetsuo Takuma, Ikuro Matsuba, Akira Kubota, Mitsuo Obana, Shinichi Umezawa, Taisuke Kikuchi, Hideo Machimura, Hiroshi Takeda, Yoko Matsuzawa, Tetsuya Motomiya, Masahiro Takihata, Kotaro Iemitsu, Hajime Maeda, Masaaki Miyakawa, Shogo Ito, Yasuo Terauchi, Taro Asakura
Publikováno v:
Diabetes Technology & Therapeutics. 22:228-234
Background: Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been repo...
Autor:
Akira Kanamori, Tetsuya Motomiya, Masahiko Takai, Hiroshi Takeda, Kotaro Iemitsu, Atsuko Mokubo, Hajime Maeda, Fuyuki Minagawa, Akira Kubota, Masashi Ishikawa, Takehiro Kawata, Tetsuo Takuma, Shinichi Umezawa, Keiji Tanaka, Hideo Machimura, Ikuro Matsuba
Publikováno v:
Journal of Clinical Medicine Research
Background: There are several reports of seasonal variation in hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2DM), but no reports of seasonal variation in the effect of add-on drugs on blood glucose control in insulin-treated patients. Me